Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Are There Any Long-Term Risks of Using Medical Cannabis for EDS? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

For individuals with Ehlers-Danlos Syndrome (EDS), medical cannabis is often explored as a potential solution for managing chronic pain treatment and other symptoms. While cannabis can provide relief, it’s important to understand the long-term cannabis risks that EDS patients might face, especially when used over extended periods. As with any therapy, understanding these EDS risks is crucial to making informed decisions about long-term use. 

Can I treat my condition with Medical Cannabis?

Understanding Long-Term Cannabis Risks In EDS 

While cannabis therapy can be an effective tool for symptom management, it’s important to be aware of potential risks, particularly with prolonged use. 

  • Tolerance and Dependency: 
    One of the long-term cannabis risks in EDS is the development of tolerance, where the body requires higher doses to achieve the same effects. This could lead to increased use, which may heighten the risk of dependency, particularly for those using cannabis as a primary form of chronic pain treatment. 
  • Mental Health Impact: 
    In some cases, long-term cannabis use may affect mental health. Some EDS patients may experience increased anxiety or other mood changes. While cannabis can help alleviate stress, its prolonged use may have the opposite effect for some individuals, particularly those using high-THC strains. 
  • Cognitive Function: 
    Prolonged cannabis use may impact cognitive function in some individuals, causing issues with memory, concentration, and learning. This is especially important for EDS patients who already face challenges due to the condition’s neurological impact. 
  • Respiratory Issues: 
    For those who choose to smoke cannabis, there is a potential risk to respiratory health. Smoking can irritate the lungs, leading to long-term complications, particularly if used frequently. Alternative consumption methods like edibles or vapourisers can reduce this risk. 

While long-term cannabis risks in EDS are present, they are not inevitable, and many of these effects can be mitigated with careful use. For those considering cannabis therapy, consulting a healthcare provider is essential to develop a balanced, long-term treatment plan.  

Visit providers like LeafEase for personalised consultations to explore safe cannabis options tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Ehlers-Danlos Syndrome. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories